Equities research analysts predict that Encompass Health Corp (NYSE:EHC) will announce earnings of $0.79 per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Encompass Health’s earnings. The lowest EPS estimate is $0.74 and the highest is $0.82. Encompass Health reported earnings per share of $0.66 in the same quarter last year, which suggests a positive year-over-year growth rate of 19.7%. The business is expected to announce its next quarterly earnings report on Thursday, October 25th.

On average, analysts expect that Encompass Health will report full year earnings of $3.54 per share for the current year, with EPS estimates ranging from $3.49 to $3.57. For the next financial year, analysts anticipate that the firm will post earnings of $3.74 per share, with EPS estimates ranging from $3.57 to $4.06. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Encompass Health.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, July 25th. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.83 by $0.16. Encompass Health had a net margin of 7.32% and a return on equity of 22.57%. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.03 billion.

EHC has been the topic of several recent analyst reports. Piper Jaffray Companies raised shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research note on Thursday, July 26th. Mizuho reissued a “buy” rating and set a $82.00 target price on shares of Encompass Health in a research note on Thursday, July 26th. Finally, Credit Suisse Group increased their target price on shares of Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, July 26th. One analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $73.00.

NYSE:EHC opened at $77.25 on Friday. Encompass Health has a one year low of $44.00 and a one year high of $82.46. The company has a debt-to-equity ratio of 1.73, a quick ratio of 1.17 and a current ratio of 1.17. The firm has a market capitalization of $7.63 billion, a price-to-earnings ratio of 27.99, a price-to-earnings-growth ratio of 1.82 and a beta of 0.31.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Stockholders of record on Monday, October 1st will be paid a dividend of $0.27 per share. This is a positive change from Encompass Health’s previous quarterly dividend of $0.25. This represents a $1.08 annualized dividend and a dividend yield of 1.40%. The ex-dividend date is Friday, September 28th. Encompass Health’s dividend payout ratio is presently 36.23%.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Further Reading: Price to Earnings Ratio (PE)

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.